Cutaneous arteritis during olaparib treatment for ovarian cancer

J Dermatol. 2021 Mar;48(3):e140-e141. doi: 10.1111/1346-8138.15749. Epub 2021 Jan 6.

Authors

Shin Iinuma¹, Chiaki Takahashi¹, Hideaki Negishi², Akemi Ishida-Yamamoto³

Affiliations

¹ Department of Dermatology, Japanese Red Cross Kitami Hospital, Kitami, Japan.
² Department of Obstetrics and Gynecology, Japanese Red Cross Kitami Hospital, Kitami, Japan.
³ Department of Dermatology, Asahikawa Medical University, Asahikawa, Japan.

PMID: 33404077
DOI: 10.1111/1346-8138.15749

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Agents* / adverse effects
Arteritis*
Female
Humans
Ovarian Neoplasms* / drug therapy
Phthalazines / adverse effects
Piperazines / adverse effects

Substances

Antineoplastic Agents
Phthalazines
Piperazines
olaparib